Stay updated on Celecoxib Impact on SMN2 in SMA Clinical Trial
Sign up to get notified when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.

Latest updates to the Celecoxib Impact on SMN2 in SMA Clinical Trial page
- CheckyesterdayChange DetectedThe page footer revision tag was updated from v3.5.3 to v3.5.4, indicating a minor site update.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s footer/version indicator was updated from Revision v3.5.2 to v3.5.3, reflecting a website release rather than a change to the trial information.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3. This appears to be a minor version update and does not alter the study information.SummaryDifference0.1%

- Check94 days agoChange DetectedThe footer now shows Revision: v3.4.2 instead of v3.4.1; no study details or content have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Celecoxib Impact on SMN2 in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.